Hidradenitis Suppurativa: Embracing Progress

JAAD Supplement, Dec 2024 – Hidradenitis Suppurativa: Embracing Progress

We’ve witnessed some welcome developments regarding #HidradenitisSuppurativa (HS) in recent years, including:

• Since 2023, two new approved treatments for moderate to severe HS in Europe, USA, and beyond
• The publication of the first Global Report on Hidradenitis Suppurativa by the Global Hidradenitis Suppurativa Atlas with the International League of Dermatological Societies (Link)
• An independent report for the European Commission listed HS as a high-burden, under-researched medical condition (Link)
• An explosion of research into HS (> 50% of all HS publications to date in the PubMed database have appeared since 01/Jan/2021 alone [PubMed records on HS extend back to 1947])
• And more besides

Reflecting these exciting times for HS, the world’s most widely read dermatology journal, The Journal of the American Academy of Dermatology (JAAD), has recently published an #openaccess #supplement dedicated to HS (“Hidradenitis suppurativa: Embracing progress”; Link).

This informative and timely publication features contributions from many well-known HS specialists, as follows:

1. Sayed CJ, Hsiao JL. Navigating the current revolution in hidradenitis suppurativa care and research. J Am Acad Dermatol. 2024 Dec;91(6S):S1-S2. doi: 10.1016/j.jaad.2024.08.058. PMID: 39626991 (Link)
2. Midgette B, Garg A. Epidemiology of hidradenitis suppurativa and its comorbid conditions. J Am Acad Dermatol. 2024 Dec;91(6S):S3-S7. doi: 10.1016/j.jaad.2024.09.013. PMID: 39626996 (Link)
3. Daveluy S, Okoye GA. Quality of life and the patient journey in hidradenitis suppurativa. J Am Acad Dermatol. 2024 Dec;91(6S):S8-S11. doi: 10.1016/j.jaad.2024.09.008. PMID: 39627002 (Link)
4. Frew JW. Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome. J Am Acad Dermatol. 2024 Dec;91(6S):S12-S16. doi: 10.1016/j.jaad.2024.08.052. PMID: 39626992 (Link)
5. Nielsen VW, Thomsen SF, Naik HB. Hidradenitis suppurativa pathogenesis: Extrinsic factors. J Am Acad Dermatol. 2024 Dec;91(6S):S17-S21. doi: 10.1016/j.jaad.2024.07.1524. PMID: 39626993 (Link)
6. Dagenet CB, Lee KH, Fragoso NM, Shi VY. Approach to the patient with hidradenitis suppurativa: Evaluating severity to guide therapy. J Am Acad Dermatol. 2024 Dec;91(6S):S22-S26. doi: 10.1016/j.jaad.2024.09.007. PMID: 39626994 (Link)
7. Charrow A, Santiago-Soltero K, Porter M. Biologics in hidradenitis suppurativa: Progress and new directions. J Am Acad Dermatol. 2024 Dec;91(6S):S27-S30. doi: 10.1016/j.jaad.2024.09.027. PMID: 39626995 (Link)
8. Jaguan D, Nguyen KT, Goldfarb N. Selective small molecule inhibitors for hidradenitis suppurativa: Today and tomorrow. J Am Acad Dermatol. 2024 Dec;91(6S):S31-S36. doi: 10.1016/j.jaad.2024.09.014. PMID: 39626997 (Link)
9. Fonjungo FE, Barnes LA, Aleshin MA. Antibiotic, hormonal/metabolic, and retinoid therapies for hidradenitis suppurativa. J Am Acad Dermatol. 2024 Dec;91(6S):S37-S41. doi: 10.1016/j.jaad.2024.09.015. PMID: 39626998 (Link)
10. Hermak S, Lev-Tov H. Integrative approaches in the management of hidradenitis suppurativa. J Am Acad Dermatol. 2024 Dec;91(6S):S42-S45. doi: 10.1016/j.jaad.2024.09.016. PMID: 39626999 (Link)
11. Pena-Robichaux V, Goldberg S. Procedural treatments for hidradenitis suppurativa. J Am Acad Dermatol. 2024 Dec;91(6S):S46-S51. doi: 10.1016/j.jaad.2024.08.072. PMID: 39627000 (Link)
12. Surapaneni V, Milosavljevic MV, Orenstein LAV. Pain management in hidradenitis suppurativa. J Am Acad Dermatol. 2024 Dec;91(6S):S52-S63. doi: 10.1016/j.jaad.2024.09.006. PMID: 39627001 (Link)

This is an extremely informative, practical, and useful resource, which is free to everyone to access.